Shopping Cart
- Remove All
- Your shopping cart is currently empty
CyPep-1 is a novel cationic lytic peptide with antitumor activity. It exerts potent cytotoxicity by interacting with the negatively charged membranes of cancer cells. CyPep-1 demonstrates strong cell lytic activity against cancer cells both in vitro and in vivo, making it useful for researching solid tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | CyPep-1 is a novel cationic lytic peptide with antitumor activity. It exerts potent cytotoxicity by interacting with the negatively charged membranes of cancer cells. CyPep-1 demonstrates strong cell lytic activity against cancer cells both in vitro and in vivo, making it useful for researching solid tumors. |
In vitro | CyPep-1 (0-40 μg/mL; 15-360 minutes) exhibits dose- and time-dependent cytotoxic effects on tumor cell lines, while affecting normal cell lines to a lesser extent. |
In vivo | CyPep-1 (intratumoral injection; 1200 µg; single dose) demonstrates antitumor effects in a mouse model of breast cancer. |
Molecular Weight | 3451.09 |
Formula | C152H265N57O35 |
Cas No. | 1319804-91-5 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.